Mpho Malima
Impact in
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
Papers in
-
- Cancer Genomics and Diagnostics 13
- Cancer-related molecular mechanisms research 2
-
- Lung Cancer Treatments and Mutations 6
- Ferroptosis and cancer prognosis 2
- Lung Cancer Diagnosis and Treatment 2
- Journals
- Nature (7 papers)Nature Cancer (4 papers)Nature Medicine (3 papers)Nature Communications (2 papers)Nature Genetics (2 papers)
- Partner nations
- United Kingdom
In The Last Decade
Mpho Malima
18 papers receiving 1.8k citations
Mpho Malima's Hit Papers
Peers
Comparison fields: 5 of 106
- Cancer Research 543
- Oncology 449
- Pulmonary and Respiratory Medicine 438
- Health, Toxicology and Mutagenesis 154
- Immunology 203
Countries citing papers authored by Mpho Malima
This map shows the geographic impact of Mpho Malima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mpho Malima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mpho Malima more than expected).
Fields of papers citing papers by Mpho Malima
This network shows the impact of papers produced by Mpho Malima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mpho Malima. The network helps show where Mpho Malima may publish in the future.
No co-authors to show.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Lung adenocarcinoma promotion by air pollutants Hit paper breakdown → | 2023 | 528 |
| 2 | Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA Hit paper breakdown → | 2023 | 255 |
| 3 | The evolution of lung cancer and impact of subclonal selection in TRACERx Hit paper breakdown → | 2023 | 188 |
| 4 | The evolution of non-small cell lung cancer metastases in TRACERx Hit paper breakdown → | 2023 | 154 |
| 5 | 2023 | 138 | |
| 6 | 2022 | 92 | |
| 7 | 2023 | 81 | |
| 8 | 2020 | 73 | |
| 9 | 2023 | 71 | |
| 10 | Ultrasensitive ctDNA detection for preoperative disease stratification in early-stage lung adenocarcinoma Hit paper breakdown → | 2025 | 62 |
| 11 | 2021 | 51 | |
| 12 | 2024 | 28 | |
| 13 | 2024 | 25 | |
| 14 | 2024 | 22 | |
| 15 | 2025 | 4 | |
| 16 | 2025 | 4 | |
| 17 | 2025 | 2 | |
| 18 | 2026 | 1 |
About Mpho Malima
Mpho Malima is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Oncology, Immunology and Molecular Biology, having authored 18 papers that have together received 1.8k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (13 papers), Lung Cancer Treatments and Mutations (6 papers), RNA modifications and cancer (5 papers), CAR-T cell therapy research (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Ferroptosis and cancer prognosis (2 papers), Cancer-related molecular mechanisms research (2 papers) and Lung Cancer Diagnosis and Treatment (2 papers). The work is most often cited by research in Cancer Research (543 citations), Oncology (449 citations), Pulmonary and Respiratory Medicine (438 citations), Health, Toxicology and Mutagenesis (154 citations) and Immunology (203 citations). Mpho Malima has collaborated with scholars based in United Kingdom. Their work appears in journals such as Nature, Nature Cancer, Nature Medicine, Nature Communications and Nature Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.